Iversen L (2006) Neurotransmitter transporters and their impact on the development of psychopharmacology. Br J Pharmacol 147(Suppl 1):S82–88

CAS  PubMed  PubMed Central  Google Scholar 

Castle L, Aubert RE, Verbrugge RR, Khalid M, Epstein RS (2007) Trends in medication treatment for ADHD. J Atten Disord 10:335–342

Article  PubMed  Google Scholar 

Kollins SH (2008) ADHD, substance use disorders, and psychostimulant treatment: current literature and treatment guidelines. J Atten Disord 12:115–125

Article  PubMed  Google Scholar 

Swanson JM, Wigal TL, Volkow ND (2011) Contrast of medical and nonmedical use of stimulant drugs, basis for the distinction, and risk of addiction: comment on Smith and Farah (2011). Psychol Bull 137:742–748

Article  PubMed  PubMed Central  Google Scholar 

DSMMD (2000) Diagnostic and statistical Manual of Mental Disorders, Fourth Edition. American Psychiatric Association, Washington, DC

Google Scholar 

SAMHSA (2015) Behavioral Health Trends in the United States: results from the 2014 National Survey on Drug Use and Health. NSDUH Series H-50, HHS Publication No (SMA) 15–4927 https://www.samhsa.gov/data/sites/default/files/NSDUH-FRR1-2014/NSDUH-FRR1-2014.pdf

Benson K, Flory K, Humphreys KL, Lee SS (2015) Misuse of stimulant medication among college students: a comprehensive review and meta-analysis. Clin Child Fam Psychol Rev 18:50–76

Article  PubMed  Google Scholar 

Compton WM, Han B, Blanco C, Johnson K, Jones CM (2018) Prevalence and correlates of prescription stimulant use, misuse, use disorders, and motivations for misuse among adults in the United States. Am J Psychiatry 175:741–755

Article  PubMed  PubMed Central  Google Scholar 

Carlezon WAJ, Konradi C (2004) Understanding the neurobiological consequences of early exposure to psychotropic drugs: linking behavior with molecules. Neuropharmacology 47:47–60

Article  CAS  PubMed  PubMed Central  Google Scholar 

Carrey N, Wilkinson M (2011) A review of psychostimulant-induced neuroadaptation in developing animals. Neurosci Bull 27:197–214

Article  CAS  PubMed  PubMed Central  Google Scholar 

Marco EM, Adriani W, Ruocco LA, Canese R, Sadile AG, Laviola G (2011) Neurobehavioral adaptations to methylphenidate: the issue of early adolescent exposure. Neurosci Biobehav Rev 35:1722–1739

Article  CAS  PubMed  Google Scholar 

Van Waes V, Steiner H (2015) Fluoxetine and other SSRI antidepressants potentiate addiction-related gene regulation by psychostimulant medications. In: Pinna G (ed) Fluoxetine: Pharmacology, Mechanisms of Action and Potential Side Effects. Nova Science Publishers, Hauppauge, NY, pp 207–225

Google Scholar 

Rushton JL, Whitmire JT (2001) Pediatric stimulant and selective serotonin reuptake inhibitor prescription trends: 1992 to 1998. Arch Pediatr Adolesc Med 155:560–565

Article  CAS  PubMed  Google Scholar 

Safer DJ, Zito JM, DosReis S (2003) Concomitant psychotropic medication for youths. Am J Psychiatry 160:438–449

Article  PubMed  Google Scholar 

Waxmonsky J (2003) Assessment and treatment of attention deficit hyperactivity disorder in children with comorbid psychiatric illness. Curr Opin Pediatr 15:476–482

Article  PubMed  Google Scholar 

Spencer TJ (2006) ADHD and comorbidity in childhood. J Clin Psychiatry 67 Suppl 8:27–31

Google Scholar 

Lavretsky H, Kim MD, Kumar A, Reynolds CF (2003) Combined treatment with methylphenidate and citalopram for accelerated response in the elderly: an open trial. J Clin Psychiatry 64:1410–1414

Article  CAS  PubMed  Google Scholar 

Nelson JC (2007) Augmentation strategies in the treatment of major depressive disorder. Recent findings and current status of augmentation strategies. CNS Spectr 12 Suppl 22:6–9

Google Scholar 

Ishii M, Tatsuzawa Y, Yoshino A, Nomura S (2008) Serotonin syndrome induced by augmentation of SSRI with methylphenidate. Psychiatry Clin Neurosci 62:246

Article  PubMed  Google Scholar 

Ravindran AV, Kennedy SH, O’Donovan MC, Fallu A, Camacho F, Binder CE (2008) Osmotic-release oral system methylphenidate augmentation of antidepressant monotherapy in major depressive disorder: results of a double-blind, randomized, placebo-controlled trial. J Clin Psychiatry 69:87–94

Article  CAS  PubMed  Google Scholar 

Csoka A, Bahrick A, Mehtonen OP (2008) Persistent sexual dysfunction after discontinuation of selective serotonin reuptake inhibitors. J Sex Med 5:227–233

Article  CAS  PubMed  Google Scholar 

Volkow ND, Wang GJ, Fowler JS, Logan J, Franceschi D, Maynard L, Ding YS, Gatley SJ, Gifford A, Zhu W, Swanson JM (2002) Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: therapeutic implications. Synapse 43:181–187

Article  CAS  PubMed  Google Scholar 

Yano M, Steiner H (2007) Methylphenidate and cocaine: the same effects on gene regulation? Trends Pharmacol Sci 28:588–596

Article  CAS  PubMed  Google Scholar 

Pan D, Gatley SJ, Dewey SL, Chen R, Alexoff DA, Ding YS, Fowler JS (1994) Binding of bromine-substituted analogs of methylphenidate to monoamine transporters. Eur J Neurosci 264:177–182

CAS  Google Scholar 

Kuczenski R, Segal DS (1997) Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine. J Neurochem 68:2032–2037

Article  CAS  PubMed  Google Scholar 

Segal DS, Kuczenski R (1999) Escalating dose-binge treatment with methylphenidate: role of serotonin in the emergent behavioral profile. J Pharmacol Exp Ther 291:19–30

CAS  PubMed  Google Scholar 

Berke JD, Paletzki RF, Aronson GJ, Hyman SE, Gerfen CR (1998) A complex program of striatal gene expression induced by dopaminergic stimulation. J Neurosci 18:5301–5310

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yuferov V, Kroslak T, Laforge KS, Zhou Y, Ho A, Kreek MJ (2003) Differential gene expression in the rat caudate putamen after binge cocaine administration: advantage of triplicate microarray analysis. Synapse 48:157–169

Article  CAS  PubMed  Google Scholar 

Yuferov V, Nielsen D, Butelman E, Kreek MJ (2005) Microarray studies of psychostimulant-induced changes in gene expression. Addict Biol 10:101–118

Article  CAS  PubMed  Google Scholar 

Black YD, Maclaren FR, Naydenov AV, Carlezon WAJ, Baxter MG, Konradi C (2006) Altered attention and prefrontal cortex gene expression in rats after binge-like exposure to cocaine during adolescence. J Neurosci 26:9656–9665

Article  CAS  PubMed  PubMed Central  Google Scholar 

Heiman M, Schaefer A, Gong S, Peterson JD, Day M, Ramsey KE, Suárez-Fariñas M, Schwarz C, Stephan DA, Surmeier DJ, Greengard P, Heintz N (2008) A translational profiling approach for the molecular characterization of CNS cell types. Cell 135:738–748

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nestler EJ (2014) Epigenetic mechanisms of drug addiction. Neuropharmacology 76, part B:259–268

Steiner H, Van Waes V (2013) Addiction-related gene regulation: risks of exposure to cognitive enhancers vs. other psychostimulants. Prog Neurobiol 100:60–80

Article  CAS  PubMed  Google Scholar 

Thanos PK, Michaelides M, Benveniste H, Wang GJ, Volkow ND (2007) Effects of chronic oral methylphenidate on cocaine self-administration and striatal dopamine D2 receptors in rodents. Pharmacol Biochem Behav 87:426–433

Article  CAS  PubMed  Google Scholar 

Robison LS, Ananth M, Hadjiargyrou M, Komatsu DE, Thanos PK (2017) Chronic oral methylphenidate treatment reversibly increases striatal dopamine transporter and dopamine type 1 receptor binding in rats. J Neural Transm 124:655–667

Article  CAS  PubMed  Google Scholar 

Yano M, Beverley JA, Steiner H (2006) Inhibition of methylphenidate-induced gene expression in the striatum by local blockade of D1 dopamine receptors: interhemispheric effects. Neuroscience 140:699–709

Article  CAS  PubMed  Google Scholar 

Alburges ME, Hoonakker AJ, Horner KA, Fleckenstein AE, Hanson GR (2011) Methylphenidate alters basal ganglia neurotensin systems through dopaminergic mechanisms: a comparison with cocaine treatment. J Neurochem 117:470–478

Article  CAS  PubMed  Google Scholar 

Bhat RV, Baraban JM (1993) Activation of transcription factor genes in striatum by cocaine: role of both serotonin and dopamine systems. J Pharmacol Exp Ther 267:496–505

CAS  PubMed  Google Scholar 

Lucas JJ, Segu L, Hen R (1997) 5-Hydroxytryptamine1B receptors modulate the effect of cocaine on c-fos expression: converging evidence using 5-hydroxytryptamine1B knockout mice and the 5-hydroxytryptamine1B/1D antagonist GR127935. Mol Pharmacol 51:755–763

Article  CAS  PubMed  Google Scholar 

Castanon N, Scearce-Levie K, Lucas JJ, Rocha B, Hen R (2000) Modulation of the effects of cocaine by 5-HT1B receptors: a comparison of knockouts and antagonists. Pharmacol Biochem Behav 67:559–566

Article  CAS  PubMed